Circuit class therapy or seven-day week therapy for increasing rehabilitation intensity of therapy after stroke (CIRCIT): a randomized controlled trial

International Journal of Stroke : Official Journal of the International Stroke Society
Coralie EnglishSusan Hillier

Abstract

Increased therapy has been linked to improvements in functional ability of people with stroke. To determine the effectiveness of two alternative models of increased physiotherapy service delivery (seven-day week therapy or group circuit class therapy five days a week) to usual care. Three-armed randomized controlled trial with blinded assessment of outcome. People admitted with a diagnosis of stroke, previously independently ambulant and with a moderate level of disability were recruited. 'Usual care' was individual physiotherapy provided five-days a week. Seven-day week therapy was usual care physiotherapy provided seven-days a week. Participants in the circuit class therapy arm of the trial received physiotherapy in group circuit classes in two 90-min sessions, five-days a week. Primary outcome was distance walked on the six-minute walk test at four-weeks post-randomization. Two hundred eighty-three participants were randomized; primary outcome data were available for 259 (92%). In the seven-day arm participants received an additional three hours of physiotherapy and those in the circuit class arm an additional 22 h. There were no significant between-group differences at four-weeks in walking distance (P = 0.72). Length of st...Continue Reading

Associated Clinical Trials

References

Feb 1, 1987·Journal of Neurology, Neurosurgery, and Psychiatry·D T Wade, R L Hewer
Jan 1, 1995·Archives of Physical Medicine and Rehabilitation·H S JørgensenT S Olsen
Dec 1, 1996·Archives of Physical Medicine and Rehabilitation·K J OttenbacherR C Fiedler
Jul 22, 1999·Archives of Physical Medicine and Rehabilitation·N D HaradaA L Stewart
Sep 3, 1999·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·G HawthorneR Osborne
Jul 7, 2001·Stroke; a Journal of Cerebral Circulation·S L WolfA Piacentino
Sep 12, 2001·Archives of Physical Medicine and Rehabilitation·N M SalbachC L Richards
Jul 26, 2003·Archives of Physical Medicine and Rehabilitation·Pamela W DuncanUNKNOWN Glycine Antagonist in Neuroprotection Americans Investigators
Oct 9, 2004·Stroke; a Journal of Cerebral Circulation·Gert KwakkelPeter Langhorne
Dec 3, 2004·The Australian Journal of Physiotherapy·Jannette Blennerhassett, Wayne Dite
Jan 13, 2006·Archives of Physical Medicine and Rehabilitation·Marianne BeninatoJoel Stein
Aug 7, 2007·Archives of Physical Medicine and Rehabilitation·Coralie K EnglishAndrea Warden-Flood
Oct 3, 2007·Archives of Physical Medicine and Rehabilitation·Jan MehrholzMarcus Pohl
Jan 31, 2008·Journal of Speech, Language, and Hearing Research : JSLHR·Jeffrey A Kleim, Theresa A Jones
Jun 24, 2008·Physiotherapy Theory and Practice·George D FulkSusan O'Sullivan
Nov 6, 2009·Nature Reviews. Neuroscience·Timothy H Murphy, Dale Corbett
Jan 19, 2011·Nature Reviews. Neurology·Michael A Dimyan, Leonardo G Cohen
Oct 4, 2011·Stroke Research and Treatment·Tanya West, Julie Bernhardt
Nov 25, 2011·International Journal of Stroke : Official Journal of the International Stroke Society·Susan HillierAdrian Esterman
Oct 6, 2012·Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy·Kathryn D ShawNatasha K Brusco
Apr 24, 2014·The Cochrane Database of Systematic Reviews·Alex PollockPeter Langhorne
May 29, 2014·Stroke; a Journal of Cerebral Circulation·Keith R LohseLara A Boyd

❮ Previous
Next ❯

Citations

Sep 18, 2016·Journal of Physiotherapy·Emma J SchneiderJulia Schmidt
Jun 20, 2017·Journal of Neurologic Physical Therapy : JNPT·Teresa Jacobson KimberleyDeborah Larsen
Jun 28, 2017·Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association·Teresa Jacobson KimberleyDeborah Larsen
Apr 8, 2018·Geriatrics & Gerontology International·Kiyotaka HasebeMasahiro Abo
Feb 7, 2018·Physiotherapy Research International : the Journal for Researchers and Clinicians in Physical Therapy·E L CaruanaS G Brauer
Jun 3, 2017·The Cochrane Database of Systematic Reviews·Coralie EnglishElizabeth A Lynch
Apr 23, 2019·Geriatrics & Gerontology International·Makiko UrumaMasahiro Abo
May 10, 2019·Australasian Journal on Ageing·Nicholas F TaylorNora Shields
Mar 21, 2020·The Cochrane Database of Systematic Reviews·David H SaundersGillian E Mead
Mar 25, 2016·The Cochrane Database of Systematic Reviews·David H SaundersGillian E Mead
Jan 11, 2017·Australian Occupational Therapy Journal·Claire StewartSuzanne Kuys
Mar 20, 2019·Topics in Stroke Rehabilitation·Daniel McEwenLucie Brosseau
Feb 8, 2020·Journal of Neuroengineering and Rehabilitation·Sung Yul ShinJames Sulzer
Jan 2, 2020·Pilot and Feasibility Studies·Emma J SchneiderNatasha A Lannin
Jul 28, 2018·Frontiers in Behavioral Neuroscience·Matthew W McDonaldDale Corbett
Jan 13, 2021·Stroke; a Journal of Cerebral Circulation·Kathryn S HaywardJulie Bernhardt
Jul 11, 2020·Journal of the American Medical Directors Association·Allison M GustavsonJennifer E Stevens-Lapsley
Aug 11, 2021·PM & R : the Journal of Injury, Function, and Rehabilitation·Yosuke KimuraMinoru Yamada
Oct 26, 2021·The Cochrane Database of Systematic Reviews·Beth ClarkJane Burridge

❮ Previous
Next ❯

Software Mentioned

AQoL
SPSS Statistics
Stata

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.